10x Genomics (TXG) revenue

Revenue · fiscal 2025
$642.82M

10x Genomics (TXG) reported revenue of $642.82M in fiscal 2025 (the year ended December 31, 2025). That is 5.2% higher than the $610.79M of fiscal 2024. Figures as of 18 Nov 2026, 10:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$642.82M
Change on fiscal 2024
+5.2%
Growth, 5 years
+16.6% a year
Highest on record
$642.82Mfiscal 2025
Lowest on record
$71.09Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

10x Genomics revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 16.6% a year. Across the 9 fiscal years on record (2017–2025), the highest was $642.82M in fiscal 2025 and the lowest $71.09M in fiscal 2017.

History · 9 fiscal years

Revenue by fiscal year

10x Genomics revenue, year by year

10x Genomics (TXG) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$642.82M 5.2% up
2024$610.79M 1.3% down
2023$618.73M 19.8% up
2022$516.41M 5.3% up
2021$490.49M 64.1% up
2020$298.85M 21.5% up
2019$245.89M 68.1% up
2018$146.31M 105.8% up
2017$71.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of 10x Genomics and comparable companies
CompanyRevenueFiscal year
Twist Bioscience TWST$459.43M2026
Protagonist Therapeutics PTGX$46.02M2025
Krystal Biotech KRYS$389.13M2025
10x Genomics TXG$642.82M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics revenue: questions and answers

What is 10x Genomics's revenue?

10x Genomics (TXG) reported revenue of $642.82M in fiscal 2025 (the year ended December 31, 2025). That is 5.2% higher than the $610.79M of fiscal 2024.

What is the growth rate of 10x Genomics's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 16.6% a year.

What are the highest and lowest revenue figures on record for 10x Genomics?

Across the 9 fiscal years on record (2017–2025), the highest was $642.82M in fiscal 2025 and the lowest $71.09M in fiscal 2017.

How is 10x Genomics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For 10x Genomics it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TXG/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.